Aspen Pharmacare 

$11.15
22
+$0.26+2.43% Wednesday 19:49

统计数据

当日最高
11.15
当日最低
10.88
52周最高
13.69
52周最低
8.45
成交量
27
平均成交量
283
市值
5.99B
市盈率
22.11
股息收益率
1.8%
股息
0.2

即将到来

股息

1.8%股息收益率
10年增长
N/A
5年增长
N/A
3年增长
4.9%
1年增长
11.6%

收益

3Sep预期
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q4 2023
Q2 2024
0
0.18
0.37
0.55
预期每股收益
0.55146
实际每股收益
0.55146

人们还关注

此列表基于关注APNHY的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Pharmaceuticals: Generic
Health Technology
Manufacturing
Medicinal and Botanical Manufacturing
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.
Show more...
首席执行官
Stephen Saad
员工
8612
国家
US
ISIN
US04530Y1064

上市公司